Company code: Shanghai General Healthy Information And Technology Co.Ltd(605186) company abbreviation: Shanghai General Healthy Information And Technology Co.Ltd(605186) Shanghai General Healthy Information And Technology Co.Ltd(605186)
Annual report for 2021
Important tips
1、 The directors and supervisors shall not be jointly and severally liable for any misrepresentation, omission or material misrepresentation of the company’s annual report, and the directors and supervisors shall not be jointly and severally liable for any misrepresentation, omission or material misrepresentation of the company’s annual report. 2、 All directors of the company attended the board meeting. 3、 Lixin Certified Public Accountants (special general partnership) issued a standard unqualified audit report for the company. 4、 Dai Jianwei, the person in charge of the company, Qiu Hong, the person in charge of accounting, and Zhu Ying, the person in charge of the accounting organization (Accounting Supervisor), declare that they guarantee the authenticity, accuracy and completeness of the financial report in the annual report. 5、 The profit distribution plan or the plan of converting accumulation fund into share capital in the reporting period adopted by the resolution of the board of directors
According to the actual operating conditions of the company and the resolution of the 11th meeting of the second board of directors, the company plans to distribute profits based on the total share capital registered on the date of equity distribution in 2021. The company’s profit distribution plan for 2021 is as follows:
Audited by Lixin Certified Public Accountants (special general partnership), the net profit attributable to the shareholders of the parent company in 2021 was 11761813799 yuan. As of December 31, 2021, the distributable profit of the parent company at the end of the period was 14396196762 yuan.
It is proposed to distribute a cash dividend of 0.9 yuan (including tax) to all shareholders for every 10 shares. As of December 31, 2021, the total share capital of the company is 136 million shares. Based on this calculation, the total cash dividend to be distributed is 1224000000 yuan (including tax), and the remaining undistributed profits are carried forward and retained to the next year. The total cash dividends of the company in this year accounted for 10.41% of the net profit attributable to the shareholders of the parent company in the consolidated statements of this year. In this profit distribution, no capital reserve will be converted into share capital and no bonus shares will be given.
If the total share capital of the company changes before the equity registration date of equity distribution, the company plans to maintain the total distribution unchanged, adjust the distribution proportion per share accordingly, and will announce the specific adjustment separately.
The profit distribution plan needs to be submitted to the general meeting of shareholders of the company for deliberation. 6、 Risk statement of forward-looking statements √ applicable □ not applicable
The company’s future plans, development strategies and other forward-looking descriptions involved in this report do not constitute the company’s substantive commitment to investors. Please pay attention to investment risks. 7、 Whether there is any non operational occupation of funds by the controlling shareholders and their related parties? VIII. Whether there is any external guarantee in violation of the specified decision-making procedures? No
9、 Whether more than half of the directors can not guarantee the authenticity, accuracy and completeness of the annual report disclosed by the company. X. tips on major risks
The company has described the possible relevant risks in this report. Please pay attention to them and refer to (IV) “possible risks” in Section III “management discussion and analysis” of this report. 11、 Others □ applicable √ not applicable
catalogue
Section 1 interpretation five
Section II Company Profile and main financial indicators Section III Management Discussion and Analysis Section 4 corporate governance Section V environmental and social responsibility 49 section VI important matters Section VII changes in shares and shareholders 75 Section VIII preferred shares 81 section 9 relevant information of bonds Section x financial report eighty-two
(I) financial statements signed and sealed by the legal representative of the company, the person in charge of accounting work and the person in charge of accounting organization
The catalogue of documents for future reference (II) contains the original audit report sealed by the accounting firm and signed and sealed by the certified public accountant
(III) originals of all company documents and announcements publicly disclosed on the website of Shanghai stock exchange during the reporting period
Section I interpretation
1、 Interpretation in this report, unless the context otherwise requires, the following words have the following meanings: Interpretation of common words
Shanghai General Healthy Information And Technology Co.Ltd(605186) , the company and the company refer to Shanghai General Healthy Information And Technology Co.Ltd(605186)
Shantao information refers to Shanghai Shantao Information Technology Co., Ltd., a wholly-owned subsidiary of the company
Welehitz refers to welehitz (Shanghai) Pharmaceutical Equipment Technology Co., Ltd., a holding subsidiary of the company
Shandong Jianhui refers to Shandong Shanghai General Healthy Information And Technology Co.Ltd(605186) Technology Co., Ltd., a wholly-owned subsidiary of the company
Shanghai Wutong refers to Shanghai Wutong Industrial Co., Ltd., a wholly-owned secondary subsidiary of the company
HK health refers to HK health fortune Co., limited, a wholly-owned level III subsidiary of the company
Shanghai shankang refers to shankang (Shanghai) Pharmaceutical Technology Co., Ltd., a holding subsidiary of the company
Shanghai Haobo refers to Shanghai Haobo Information Technology Co., Ltd., a wholly-owned subsidiary of the company
Shanghai Jianqing refers to Shanghai Jianqing Information Technology Co., Ltd., a wholly-owned subsidiary of the company
Yaozhi information refers to Yaozhi (Shanghai) Information Technology Co., Ltd., a secondary subsidiary of the company
Cathay Pacific Weiye refers to Tianjin Cathay Pacific Weiye medical device sales Co., Ltd., a secondary subsidiary of the company
Willach means willach pharmaceutical solutions GmbH
Newicon means newicon oy
Boke Guoxin refers to Wuhan Boke Guotai Information Technology Co., Ltd., a joint-stock company of the company
Jianchuo century refers to jianchuo Century (Tianjin) Technology Co., Ltd., a joint-stock company of the company
Guangdong Jianhui refers to Guangdong Shanghai General Healthy Information And Technology Co.Ltd(605186) Technology Co., Ltd., a joint-stock company of the company
Gaoji medical refers to Gaoji Pharmaceutical Co., Ltd
Yifeng pharmacy refers to Yifeng Pharmacy Chain Co.Ltd(603939)
Dingdang quick medicine refers to Dingdang smart pharmacy (Beijing) Co., Ltd
Shanghai No.1 Pharmacy Co.Ltd(600833) refers to Shanghai No.1 Pharmacy Co.Ltd(600833)
Lbx Pharmacy Chain Joint Stock Company(603883) pharmacy refers to Lbx Pharmacy Chain Joint Stock Company(603883) pharmacy chain (Shanghai) Co., Ltd
Recommended investment refers to Shanghai recommended Investment Management Co., Ltd
Pingsheng Ankang refers to Pingsheng Ankang equity investment fund partnership (limited partnership) in Ningbo Meishan free trade port area
Huagai Xincheng refers to Beijing Huagai Xincheng Yuanhang medical industry investment partnership (limited partnership)
Hybio Pharmaceutical Co.Ltd(300199) refers to Hybio Pharmaceutical Co.Ltd(300199)
Ningbo Hydra refers to Hydra equity investment partnership (limited partnership) in Ningbo Free Trade Zone
Chongqing Boyi refers to Chongqing Boyi Xintian equity investment fund partnership (limited partnership)
His refers to hospital information system
SPD refers to the supply process and distribution system
To-g refers to government, a government customer
CSRC and CSRC refer to the China Securities Regulatory Commission
Shanghai Securities Regulatory Bureau refers to the Shanghai regulatory bureau of China Securities Regulatory Commission
Shanghai stock exchange refers to Shanghai Stock Exchange
Company Law refers to the company law of the people’s Republic of China
Securities Law refers to the securities law of the people’s Republic of China
The articles of association refers to Shanghai General Healthy Information And Technology Co.Ltd(605186) articles of association
The reporting period refers to the period from January 1, 2021 to December 31, 2021
Yuan and 10000 yuan refer to RMB yuan and 10000 yuan
Section II Company Profile and main financial indicators
1、 Company information
Chinese name of the company Shanghai General Healthy Information And Technology Co.Ltd(605186)
Chinese company abbreviation 186
Shanghai general health information and
Technology Co., Ltd.
The abbreviation of the company’s foreign name is general health
The legal representative of the company is Dai Jianwei
2、 Contact person and contact information
Secretary of the board of directors
Name: Qiu Hong
Contact address: No. 518, Zhongchen Road, Songjiang District, Shanghai
Tel: 02158380355
Fax 02158380355
E-mail stock@g -healthy. com.
Note: Recently, the company’s office address has changed. At present, Shanghai is in the key stage of epidemic prevention and control, and the fax of the company’s new office has not been connected. Investors can contact through telephone and e-mail.
After the end of the epidemic, the company will contact the communication service provider to connect the fax number as soon as possible. Please pay attention to investors. 3、 Basic information
Registered address: room 104, building 1, No. 299, Zhongchen Road, Songjiang District, Shanghai
Historical change of the company’s registered address in 2015, the company changed from “room 255, No. 11, Lane 2165, Wangyuan Road, Fengxian District, Shanghai” to “room 566, building 23, No. 518, Xinzhuan Road, Songjiang high tech park, Caohejing Development Zone, Shanghai”; In 2017, the company changed from “room 566, building 23, No. 518, Xinzhuan Road, Songjiang high tech park, Caohejing Development Zone, Shanghai” to “room 222, No. 668, Xinzhuan Road, Songjiang District, Shanghai”; In 2018, the company changed from “room 222, No. 668, Xinzhuan Road, Songjiang District, Shanghai” to “room 104, building 1, No. 299, Zhongchen Road, Songjiang District, Shanghai”.
Office address: No. 518, Zhongchen Road, Songjiang District, Shanghai
The postal code of the company’s office address is 201613
Company website http://www.g-healthy.com./
E-mail stock@g -healthy. com.
4、 Information disclosure and preparation location
Media name and website of the annual report disclosed by the company
